Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Dow
Merck
Moodys
Johnson and Johnson

Last Updated: April 5, 2020

DrugPatentWatch Database Preview

Iron sucrose - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for iron sucrose and what is the scope of patent protection?

Iron sucrose is the generic ingredient in one branded drug marketed by Am Regent and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are eighty-two drug master file entries for iron sucrose. Three suppliers are listed for this compound.

Summary for iron sucrose
Recent Clinical Trials for iron sucrose

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Quotient SciencesPhase 1
Baxter Healthcare CorporationPhase 1
University Medical Centre LjubljanaPhase 3

See all iron sucrose clinical trials

Pharmacology for iron sucrose
Synonyms for iron sucrose
C12H22O11.2Fe.3O
Colliron I.V
Colliron I.V.
DB09146
EINECS 232-464-7
Encifer
Fe-back
Fe-lib
Feojectin
Ferijet
Ferosoft S
Ferplex SS
FERRIC HYDROXIDE SUCROSE COMPLEX
Ferric oxide, saccharated
Ferric saccharate ...iron oxide (mix.)
Ferrivenin
Ferrum Hausmann i.v.
Ferrum Vitis
Ferum Hausmann
Fesin
FZ7NYF5N8L
Hippiron
Hippiron (Iron Sucrose), Ferrum Hausmann IV
IRON OXIDE SACCHARATED
Iron oxide, saccharated
Iron oxide, saccharated, Iron saccharate
Iron sucrose [USAN:USP:BAN]
Iron sucrose [USAN]
IRON SUCROSE COMPLEX
Iron sugar
IRON(III) HYDROXIDE SUCROSE COMPLEX
Iviron
LS-84269
Neo-ferrum
Proferrin
Q27888379
Saccharated ferric oxide
Saccharated iron
Saccharated iron oxide
Succharated ferric oxide
Succharated ferric oxide [USAN:JAN]
Sucrofer
Sucroferric oxyhydroxide
Sucrose, iron complex
UNII-FZ7NYF5N8L
Velphoro
Venofer
Venoferrum
XI 921
XI-921

US Patents and Regulatory Information for iron sucrose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-003 Mar 29, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Am Regent VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-005 Mar 29, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
Am Regent VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-001 Nov 6, 2000 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Dow
Merck
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.